GKB Ophthalmics Ltd.

85.50 +1.10 ▲1.3%

29 February 2024, 04:01:00 PM
Volume: 1,901

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Industry Icon Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.gkb.net
Market Cap 43.80 Cr.
Enterprise Value(EV) 37.99 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -7.56 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 58.60 Trailing Twelve Months Ending 2023-12
Book Value / Share 120.43 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.72 Calculated using Price: 86.90
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.50 Cr. 5,040,580 Shares
FaceValue 10
About GKB Ophthalmics Ltd.
The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

GKB Ophthalmics Ltd. Delivery

Delivered Qty
Traded Qty

GKB Ophthalmics Ltd. Performance

1 Day
+1.30%
1 Week
-3.77%
1 Month
-10.89%
3 Month
-11.40%
6 Month
-5.93%
1 Year
-25.72%
2 Year
-7.62%
5 Year
-25.65%
10 Year
+175.81%

GKB Ophthalmics Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -3.3 9.32 5.65 -2.12 -2.52 -4.41 -1.23 3.09 0.18
Return on Capital Employed (%) 0.82 18.94 7.99 0.25 -0.34 -1.38 1.48 4.58 2.44
Return on Assets (%) -1.78 5.48 3.34 -1.15 -1.36 -2.41 -0.69 1.73 0.1

GKB Ophthalmics Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 40 45 47 45 55 59 63 63 63 62
Non Curr. Liab. 2 2 2 2 5 5 6 8 7 3
Curr. Liab. 33 23 37 36 37 41 38 39 41 42
Minority Int. 4 4 5 5
Equity & Liab. 75 69 86 83 97 106 111 114 116 113
Non Curr. Assets 29 18 19 19 33 33 37 38 32 28
Curr. Assets 46 51 66 64 64 73 74 76 84 85
Misc. Exp. not W/O
Total Assets 75 69 86 83 97 106 111 114 116 113

GKB Ophthalmics Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 35 44 74 77 57 59 57 71 75 87
Other Income 1 2 1 0 2 1 2 1 1 1
Total Income 36 46 75 78 59 59 59 72 76 88
Total Expenditure -34 -46 -72 -76 -56 -56 -55 -66 -72 -86
PBIDT 1 0 3 2 3 3 4 6 5 1
Interest -3 -2 -1 -1 -1 -1 -2 -1 -2 -2
Depreciation -2 -1 -1 -2 -4 -4 -3 -3 -3 -4
Taxation 1 -4 0 0 0 0 0 0
Exceptional Items 1 11 3 -1
PAT -1 4 3 -1 -1 -2 -1 2 0 -4
Minority Interest 0 -1 0 0
Share Associate 1 0 1 0
Other Related Items
Consolidated Net Profit 4 3 -1 -1 -2 -1 1 0 -4
Adjusted EPS 0 10 6 -2 -2 -4 -2 3 0 -8

GKB Ophthalmics Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 6 7 -11 -3 -3 4 3 7 5 -3
Cash Fr. Inv. -2 -1 15 4 1 -10 -4 -17 -4 1
Cash Fr. Finan. -5 -6 -3 -1 1 13 4 3 -2 -2
Net Change 0 1 0 -1 0 7 4 -7 0 -4
Cash & Cash Eqvt 2 3 3 2 2 9 13 6 6 2

GKB Ophthalmics Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 59.69 59.72 59.73 59.16 59.09 59.09 59.18 50.86 50.88
Public 40.31 40.28 40.27 40.84 40.91 40.91 40.82 49.14 49.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

GKB Ophthalmics Ltd. Announcements

Fri, 16 Feb 2024
Extract Of Statement Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2023.
Please find attached copies of newspaper cuttings of the extract of the Unaudited Standalone and Consolidated Financial results for the quarter and nine months ended December 31 2023 published in The Financial Express ( Mumbai Edition) and on Pudhari ( Marathi) dated February 16 2024.
Wed, 14 Feb 2024
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations 2015
Pursuant to Regulation 32 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations 2015 enclosed please find the Statement of Deviation or Variation for the quarter ended December 31 2023.
Wed, 14 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On February 14 2024.
The meeting of the Board of Directors of the Company was held on February 14 2024 which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 enclosed please find the following :1. Standalone Financial Results for the quarter and nine months ended December 31 2023 together with the Limited Review Report.2. Consolidated Financial Results for the quarter and nine months ended December 31 2023 together with the Limited Review Report.The Board of Directors Meeting started at 4.45 P.M. and ended at 06.25 P.M. on the same day.Kindly take the information on record.

GKB Ophthalmics Ltd. Technical Scans

Wed, 28 Feb 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

GKB Ophthalmics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 377,475.37 1,577.95 +0.3%
Cipla Ltd. 119,187.32 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,206.64 6,424.25 -0.1%
Zydus Lifesciences Ltd. 94,418.40 941.90 +1.0%
Divi's Laboratories Ltd. 93,236.55 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. 91,390.97 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. 88,302.11 2,666.80 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.38 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.14 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.51 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.75 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 67.42 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.78 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,666.80 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.05 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.60 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.86 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.15 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.53 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,666.80 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%

GKB Ophthalmics Ltd. FAQ's

What is GKB Ophthalmics share price?

Can I buy GKB Ophthalmics shares now?

What is the Market Cap of GKB Ophthalmics?

What are the key metrics to analyse GKB Ophthalmics?

What is the 52 Week High and Low of GKB Ophthalmics?

What is the trend of GKB Ophthalmics share price?